Global Brain Tumor Treatment Market Size, Status and Forecast 2019-2025

Description

Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient's age and general health.
Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms and slow down the tumor's growth.
In 2018, the global Brain Tumor Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Brain Tumor Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Brain Tumor Treatment development in United States, Europe and China.

The key players covered in this study
Genetech (U.S.)
Bristol Mayers Squibb (U.S.)
Hoffman-La Roche (Switzerland)
Astra Zeneca (India)
Pfizer (U.S.)
Novartis (Switzerland)
Antisenese Pharma (Mongolia)
Merck (U.S.)
Mcleod's Pharmaceuticals (India)
Mankind Pharma (India)
Dr. Reddy's Laboratories (India)

Market segment by Type, the product can be split into
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Others

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Brain Tumor Treatment status, future forecast, growth opportunity, key market and key players.
To present the Brain Tumor Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Brain Tumor Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Brain Tumor Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Chemotherapy
1.4.5 Immunotherapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Brain Tumor Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Brain Tumor Treatment Market Size
2.2 Brain Tumor Treatment Growth Trends by Regions
2.2.1 Brain Tumor Treatment Market Size by Regions (2014-2025)
2.2.2 Brain Tumor Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Brain Tumor Treatment Market Size by Manufacturers
3.1.1 Global Brain Tumor Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Brain Tumor Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Brain Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Brain Tumor Treatment Key Players Head office and Area Served
3.3 Key Players Brain Tumor Treatment Product/Solution/Service
3.4 Date of Enter into Brain Tumor Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Brain Tumor Treatment Market Size by Type (2014-2019)
4.2 Global Brain Tumor Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Brain Tumor Treatment Market Size (2014-2019)
5.2 Brain Tumor Treatment Key Players in United States
5.3 United States Brain Tumor Treatment Market Size by Type
5.4 United States Brain Tumor Treatment Market Size by Application

6 Europe
6.1 Europe Brain Tumor Treatment Market Size (2014-2019)
6.2 Brain Tumor Treatment Key Players in Europe
6.3 Europe Brain Tumor Treatment Market Size by Type
6.4 Europe Brain Tumor Treatment Market Size by Application

7 China
7.1 China Brain Tumor Treatment Market Size (2014-2019)
7.2 Brain Tumor Treatment Key Players in China
7.3 China Brain Tumor Treatment Market Size by Type
7.4 China Brain Tumor Treatment Market Size by Application

8 Japan
8.1 Japan Brain Tumor Treatment Market Size (2014-2019)
8.2 Brain Tumor Treatment Key Players in Japan
8.3 Japan Brain Tumor Treatment Market Size by Type
8.4 Japan Brain Tumor Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Brain Tumor Treatment Market Size (2014-2019)
9.2 Brain Tumor Treatment Key Players in Southeast Asia
9.3 Southeast Asia Brain Tumor Treatment Market Size by Type
9.4 Southeast Asia Brain Tumor Treatment Market Size by Application

10 India
10.1 India Brain Tumor Treatment Market Size (2014-2019)
10.2 Brain Tumor Treatment Key Players in India
10.3 India Brain Tumor Treatment Market Size by Type
10.4 India Brain Tumor Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Brain Tumor Treatment Market Size (2014-2019)
11.2 Brain Tumor Treatment Key Players in Central & South America
11.3 Central & South America Brain Tumor Treatment Market Size by Type
11.4 Central & South America Brain Tumor Treatment Market Size by Application

12 International Players Profiles
12.1 Genetech (U.S.)
12.1.1 Genetech (U.S.) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Brain Tumor Treatment Introduction
12.1.4 Genetech (U.S.) Revenue in Brain Tumor Treatment Business (2014-2019)
12.1.5 Genetech (U.S.) Recent Development
12.2 Bristol Mayers Squibb (U.S.)
12.2.1 Bristol Mayers Squibb (U.S.) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Brain Tumor Treatment Introduction
12.2.4 Bristol Mayers Squibb (U.S.) Revenue in Brain Tumor Treatment Business (2014-2019)
12.2.5 Bristol Mayers Squibb (U.S.) Recent Development
12.3 Hoffman-La Roche (Switzerland)
12.3.1 Hoffman-La Roche (Switzerland) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Brain Tumor Treatment Introduction
12.3.4 Hoffman-La Roche (Switzerland) Revenue in Brain Tumor Treatment Business (2014-2019)
12.3.5 Hoffman-La Roche (Switzerland) Recent Development
12.4 Astra Zeneca (India)
12.4.1 Astra Zeneca (India) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Brain Tumor Treatment Introduction
12.4.4 Astra Zeneca (India) Revenue in Brain Tumor Treatment Business (2014-2019)
12.4.5 Astra Zeneca (India) Recent Development
12.5 Pfizer (U.S.)
12.5.1 Pfizer (U.S.) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Brain Tumor Treatment Introduction
12.5.4 Pfizer (U.S.) Revenue in Brain Tumor Treatment Business (2014-2019)
12.5.5 Pfizer (U.S.) Recent Development
12.6 Novartis (Switzerland)
12.6.1 Novartis (Switzerland) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Brain Tumor Treatment Introduction
12.6.4 Novartis (Switzerland) Revenue in Brain Tumor Treatment Business (2014-2019)
12.6.5 Novartis (Switzerland) Recent Development
12.7 Antisenese Pharma (Mongolia)
12.7.1 Antisenese Pharma (Mongolia) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Brain Tumor Treatment Introduction
12.7.4 Antisenese Pharma (Mongolia) Revenue in Brain Tumor Treatment Business (2014-2019)
12.7.5 Antisenese Pharma (Mongolia) Recent Development
12.8 Merck (U.S.)
12.8.1 Merck (U.S.) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Brain Tumor Treatment Introduction
12.8.4 Merck (U.S.) Revenue in Brain Tumor Treatment Business (2014-2019)
12.8.5 Merck (U.S.) Recent Development
12.9 Mcleod's Pharmaceuticals (India)
12.9.1 Mcleod's Pharmaceuticals (India) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Brain Tumor Treatment Introduction
12.9.4 Mcleod's Pharmaceuticals (India) Revenue in Brain Tumor Treatment Business (2014-2019)
12.9.5 Mcleod's Pharmaceuticals (India) Recent Development
12.10 Mankind Pharma (India)
12.10.1 Mankind Pharma (India) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Brain Tumor Treatment Introduction
12.10.4 Mankind Pharma (India) Revenue in Brain Tumor Treatment Business (2014-2019)
12.10.5 Mankind Pharma (India) Recent Development
12.11 Dr. Reddy's Laboratories (India)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

Checkout Inquiry Sample